CirChem AB (CRB) Stock Statistics & Valuation Metrics

CirChem AB has a market cap or net worth of €4.20M. The enterprise value is €42.81M.

CirChem AB has 40,205,837 shares outstanding. The number of shares has decreased by -2.65% in one year.

CirChem AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of CirChem AB is ―. CirChem AB’s PEG ratio is -0.00327.

In the last 12 months, CirChem AB had revenue of 9.96M and earned -12.05M in profits. Earnings per share was -0.33.

In the last 12 months, operating cash flow was -13.70M and capital expenditures -6.87M, giving a free cash flow of -20.57M billion.

CirChem AB pays an annual dividend of ―, resulting in a dividend yield of ―

CirChem AB upcoming earnings date is May 19, 2026, Before Open (Confirmed).

CirChem AB as a current ratio of 1.39, with Debt / Equity ratio of 29.09%

In the past 12 months, CirChem AB has paid 0.00 in taxes.

CirChem AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

CirChem AB has €13.65M in cash and marketable securities with €12.90M in debt, giving a net cash position of €751.00K billion.

Gross margin is 48.14%, with operating margin of -112.85%, and net profit margin of -121.00%.

The average price target for CirChem AB is ―, which is 11.43% higher than the current price. The consensus rating is ―